Figure 2From: Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials(A) Risk-based infection-blocking efficacy for a vaccine under the range of transmission heterogeneities in Table 2. (B) Risk-based infection-blocking efficacy for the four vaccines described in Table 3 with the same individual efficacy. (C) Rate-based infection-blocking efficacy under different transmission heterogeneities. (D) Rate-based infection-blocking efficacy for the four vaccines.Back to article page